drugset / Trial / NCT01575574
Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis
NaSingle-groupOpen-labelDiagnostic
Summary
This is a study to evaluate the primovist as a new contrast agent useful to diagnostic of hepatocellular carcinoma
Timeline
- Start
- 2012-07
- Primary completion
- 2016-07
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GADOXETIC ACID | Diagnostic / imaging agent | 0.025 unknown | Other |